Clearmind Medicine Inc. (CMND) vs Jupiter Neurosciences, Inc. (JUNS)

A side-by-side comparison of Clearmind Medicine Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CMND

Clearmind Medicine Inc.

$1M

$5.73HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

JUNS

Jupiter Neurosciences, Inc.

$1M

$2.56HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — CMND vs JUNS

growth of $100 · dividends reinvested · last 2y

CMND -99.9% (-96.2%/yr)JUNS -99.4% (-92.3%/yr)JUNS compounded faster over this window

CMND JUNS

CMND vs JUNS: by the numbers

•JUNS is the larger company ($1M vs $1M market cap).
•Both run net losses; CMND's is the smaller (0.00% vs -14220.12% net margin).

Metrics side by side

Valuation

Metric	CMND	JUNS
P/S ratio	N/A	19.18
P/B ratio	0.08	N/A

Profitability

Metric	CMND	JUNS
Gross margin	0.00%	88.34%
Operating margin	0.00%	-40873.19%
Net margin	0.00%	-14220.12%
ROE	-57.87%	N/A
ROIC	-60.41%	-709.40%

Growth (annualized)

Metric	CMND	JUNS
Revenue CAGR (5Y)	N/A	-47.77%

Go deeper

Full CMND analysis Full JUNS analysis Interactive comparison tool

Dig into the metrics

Clearmind Medicine ROE Jupiter Neurosciences ROE Clearmind Medicine operating margin Jupiter Neurosciences operating margin Clearmind Medicine revenue growth Jupiter Neurosciences revenue growth Clearmind Medicine free cash flow Jupiter Neurosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.